Switch theme
Sign up to access all valuation multiples
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
1989
275
LTM Revenue $207M
LTM EBITDA -$76.9M
-$33.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amarin Corp has a last 12-month revenue (LTM) of $207M and a last 12-month EBITDA of -$76.9M.
In the most recent fiscal year, Amarin Corp achieved revenue of $229M and an EBITDA of -$74.2M.
Amarin Corp expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amarin Corp valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $207M | XXX | $229M | XXX | XXX | XXX |
| Gross Profit | $87.7M | XXX | $81.4M | XXX | XXX | XXX |
| Gross Margin | 42% | XXX | 36% | XXX | XXX | XXX |
| EBITDA | -$76.9M | XXX | -$74.2M | XXX | XXX | XXX |
| EBITDA Margin | -37% | XXX | -32% | XXX | XXX | XXX |
| EBIT | -$80.4M | XXX | -$91.8M | XXX | XXX | XXX |
| EBIT Margin | -39% | XXX | -40% | XXX | XXX | XXX |
| Net Profit | -$71.6M | XXX | -$82.2M | XXX | XXX | XXX |
| Net Margin | -35% | XXX | -36% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Amarin Corp's stock price is $12.
Amarin Corp has current market cap of $241M, and EV of -$33.2M.
See Amarin Corp trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$33.2M | $241M | XXX | XXX | XXX | XXX | $-3.38 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Amarin Corp has market cap of $241M and EV of -$33.2M.
Amarin Corp's trades at -0.1x EV/Revenue multiple, and 0.4x EV/EBITDA.
Equity research analysts estimate Amarin Corp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amarin Corp has a P/E ratio of -3.4x.
See valuation multiples for Amarin Corp and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $241M | XXX | $241M | XXX | XXX | XXX |
| EV (current) | -$33.2M | XXX | -$33.2M | XXX | XXX | XXX |
| EV/Revenue | -0.2x | XXX | -0.1x | XXX | XXX | XXX |
| EV/EBITDA | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBIT | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/Gross Profit | -0.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.4x | XXX | -2.9x | XXX | XXX | XXX |
| EV/FCF | 1.5x | XXX | 1.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmarin Corp's last 12 month revenue growth is -12%
Amarin Corp's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.6M for the same period.
Amarin Corp's rule of 40 is -28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Amarin Corp's rule of X is -67% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Amarin Corp and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -12% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -37% | XXX | -32% | XXX | XXX | XXX |
| EBITDA Growth | -35% | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | -28% | XXX | -44% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -67% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 76% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amarin Corp acquired XXX companies to date.
Last acquisition by Amarin Corp was XXXXXXXX, XXXXX XXXXX XXXXXX . Amarin Corp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Amarin Corp founded? | Amarin Corp was founded in 1989. |
| Where is Amarin Corp headquartered? | Amarin Corp is headquartered in United States of America. |
| How many employees does Amarin Corp have? | As of today, Amarin Corp has 275 employees. |
| Who is the CEO of Amarin Corp? | Amarin Corp's CEO is Mr. Aaron D. Berg. |
| Is Amarin Corp publicy listed? | Yes, Amarin Corp is a public company listed on NAS. |
| What is the stock symbol of Amarin Corp? | Amarin Corp trades under AMRN ticker. |
| When did Amarin Corp go public? | Amarin Corp went public in 1993. |
| Who are competitors of Amarin Corp? | Similar companies to Amarin Corp include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Amarin Corp? | Amarin Corp's current market cap is $241M |
| What is the current revenue of Amarin Corp? | Amarin Corp's last 12 months revenue is $207M. |
| What is the current revenue growth of Amarin Corp? | Amarin Corp revenue growth (NTM/LTM) is -12%. |
| What is the current EV/Revenue multiple of Amarin Corp? | Current revenue multiple of Amarin Corp is -0.2x. |
| Is Amarin Corp profitable? | Yes, Amarin Corp is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Amarin Corp? | Amarin Corp's last 12 months EBITDA is -$76.9M. |
| What is Amarin Corp's EBITDA margin? | Amarin Corp's last 12 months EBITDA margin is -37%. |
| What is the current EV/EBITDA multiple of Amarin Corp? | Current EBITDA multiple of Amarin Corp is 0.4x. |
| What is the current FCF of Amarin Corp? | Amarin Corp's last 12 months FCF is -$22.7M. |
| What is Amarin Corp's FCF margin? | Amarin Corp's last 12 months FCF margin is -11%. |
| What is the current EV/FCF multiple of Amarin Corp? | Current FCF multiple of Amarin Corp is 1.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
